doi: 10.5694/mja2.51394.


Online ahead of print.

Affiliations

Item in Clipboard

Joshua Wong et al.


Med J Aust.


.

No abstract available


Keywords:

Adverse drug reactions; COVID-19; Vaccination.

References

    1. Daniels CJ, Rajpal S, Greenshields JT, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the Big Ten COVID-19 Cardiac Registry. JAMA Cardiol 2021; 6: 1078-1087.

    1. Australian Government. Guidance on myocarditis and pericarditis after mRNA COVID-19 vaccines. Canberra: Australian Government, 2021. https://www.health.gov.au/sites/default/files/documents/2021/11/covid-19… (viewed Jan 2022).

    1. Gargano JW, Wallace M, Hadler SC, et al. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices – United States, June 2021. MMWR Morb Mortal Wkly Rep 2021; 70: 977-982.

    1. Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation 2021; 144: 471-484.

    1. Montgomery J, Ryan M, Engler R, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US Military. JAMA Cardiol 2021; 6: 1202-1206.